Add Yahoo as a preferred source to see more of our stories on Google. The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating ...

Add Yahoo as a preferred source to see more of our stories on Google. In a move that could reshape how doctors approach both weight and heart health, the American College of Cardiology (ACC) released ...

The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new guidelines about glucagon-like peptide-1 (GLP-1) medications in the medical ...

GLP-1 receptor agonists for obesity are effective over the long term when paired with lifestyle interventions, but global accessibility must be improved, the World Health Organization (WHO) concluded.

The WHO recommended GLP-1s as a treatment for obesity alongside a healthy diet and regular exercise. Milles Team/Stocksy The World Health Organization (WHO) has recommended the use of GLP-1 ...

The Indian government has released details on GLP-1 drugs for diabetes and obesity, explaining their function and risks. Amid ...

A new World Health Organization (WHO) guideline recommending GLP-1s for obesity treatment along with recent efforts to reduce the drugs’ costs are unlikely to change US obesity practice — but actions ...

American Academy of Pediatrics guidelines that set off a new era in obesity treatment — and a national debate about whether children should be prescribed weight loss drugs — may have been shaped by ...

The Government of India has tightened regulation of GLP-1 drugs used for diabetes and weight loss, restricting prescriptions ...

GLP-1 drugs now have new guidelines The World Health Organization has laid down its first guidelines for GLP-1 drugs like Wegovy and Zepbound.

Glucagon-like peptide-1 (GLP-1), a naturally occurring hormone, was first identified decades ago—long before medications like Ozempic ® (semaglutide) or Mounjaro ® (tirzepatide) were developed. After ...

The World Health Organization (WHO) has recommended the use of GLP-1 medications as part of treatment programs to help people manage obesity. In a new guideline published in JAMA, WHO officials said ...